Industry Experts

Sandeep Yadav, Ph.D., is currently Vice President, Technical Development at Sangamo Therapeutics advancing genomic medicines from discovery to commercialization. He is also the founder of SY Biopharma Consulting LLC, providing senior CMC strategy and technical operations leadership to biotech pipelines. His experience spans AAV gene therapy, cell therapy, biologics, and small molecules, alongside FDA and EMA regulatory strategy, CDMO oversight, and pharmaceutical M&A due diligence. Prior to Sangamo, he held several leadership positions at Genentech/Roche and contributed to various clinical and commercial programs including Tecentriq®, Ocrevus®, Rituxan®, Avastin®, and Pulmozyme®. Across these roles, he has guided programs from clinical development through commercialization, bringing deep expertise in process development, manufacturing, and global regulatory submissions. A recognized thought leader with >30 publications and patents, Dr. Yadav is an active voice at leading industry forums and is driven by delivering capital-efficient, patient-focused CMC strategies that speed transformative medicines from development to the clinic.